COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,703 Articles (22,913 medRxiv, 8,790 bioRxiv)

Most recent first Previous |  Page 2205: Articles 22041-22050  | Next

Ongoing Adaptive Evolution and Globalization of Sars-Cov-2
Rochman, N. D., Wolf, Y. I., Faure, G., Zhang, F., Koonin, E. V.
10.1101/2020.10.12.336644 — Posted: 2020-10-16
Shark conservation risks associated with the use of shark liver oil in SARS-CoV-2 vaccine development
Macdonald, C., Soll, J.
10.1101/2020.10.14.338053 — Posted: 2020-10-15
Design of SARS-CoV-2 RBD mRNA Vaccine Using Novel Ionizable Lipids
Elia, U., Srinivas, R., Dammes, N., Bar-Haim, E., Naidu, G. S., Makdasi, E., Cohen, O., Peer, D.
10.1101/2020.10.15.341537 — Posted: 2020-10-15
A Common Methodological Phylogenomics Framework for intra-patient heteroplasmies to infer SARS-CoV-2 sublineages and tumor clones
Utro, F., Levovitz, C., Rhrissorrakrai, K., Parida, L.
10.1101/2020.10.14.339986 — Posted: 2020-10-15
Quantitative Assays Reveal Cell Fusion at Minimal Levels of SARS-CoV-2 Spike Protein and Fusion-from-Without
Theuerkauf, S. A., Michels, A., Riechert, V., Maier, T. J., Flory, E., Cichutek, K., Buchholz, C. J.
10.1101/2020.10.15.340604 — Posted: 2020-10-15
Integrated characterization of SARS-CoV-2 genome, microbiome, antibiotic resistance and host response from single throat swabs
Lu, B., Yan, Y., Dong, L., Han, L., Liu, Y., Yu, J., Chen, J., Yi, D., Zhang, M., Wang, C., Wang, R., Wang, D., Wei, H., Liu, D., Yi, C.
10.1101/2020.10.15.340794 — Posted: 2020-10-15
Systematic analysis of innate immune antagonism reveals vulnerabilities of SARS-CoV-2
Hayn, M., Hirschenberger, M., Koepke, L., Straub, J. H., Nchioua, R., Klute, S., Prelli Bozzo, C., Aftab, W., Zech, F., Conzelmann, C., Mueller, J. A., Srinivasachar Badarinarayan, S., Stuerzel, C. M., Forne, I., Stenger, S., Conzelmann, K.-K., Muench, J., Sauter, D., Imhof, A., Kirchhoff, F., Sparrer, K. M. J.
10.1101/2020.10.15.340612 — Posted: 2020-10-15
Evidence of antigenic imprinting in sequential Sarbecovirus immunization
Lv, H., So, R. T. Y., Yuan, M., Liu, H., Lee, C.-C. D., Yip, G. K., Ng, W. W., Wilson, I. A., Peiris, J. S. M., Wu, N. C., Mok, C. K. P.
10.1101/2020.10.14.339465 — Posted: 2020-10-15
The Strand-biased Transcription of SARS-CoV-2 and Unbalanced Inhibition by Remdesivir
Zhao, Y., Sun, J., Li, Y., Li, Z., Xie, Y., Feng, R., Zhao, J., Hu, Y.
10.1101/2020.10.15.325050 — Posted: 2020-10-15
Multiplexed proteomics and imaging of resolving and lethal SARS-CoV-2 infection in the lung
Kalocsay, M., Maliga, Z., Nirmal, A. J., Eisert, R. J., Bradshaw, G. A., Solomon, I. H., Chen, Y.-A., Pelletier, R. J., Jacobson, C. A., Mintseris, J., Padera, R. F., Martinot, A. J., Barouch, D. H., Santagata, S., Sorger, P.
10.1101/2020.10.14.339952 — Posted: 2020-10-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).